Miravant Medical Technologies MRVT
$0.00
Last Updated: Jun 14, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Miravant Medical Technologies. Stock Analysis MRVT
United States N/A Nano Cap Miravant Medical Technologies engages in the research and development of drugs and medical device products for the use in proprietary technologies for photodynamic therapy. The company is headquartered in Santa Barbara, California and currently employs 47 full-time employees. The drug and light procedures involve three components, the photoselective drugs, light producing devices and light delivery devices. The firm's products have been developed in-house and with outside collaborators and have been used in various clinical and preclinical investigations. Its most advanced drug, PHOTREX, generic name rostaporfin, has completed two Phase III clinical trials for the treatment of wet age-related macular degeneration (AMD). Miravant has branded its version of PDT technology with the trademark PhotoPoint.
Miravant Medical Technologies (MRVT) Chart
Financial Metrics & Statements of Miravant Medical Technologies (MRVT)
FAQ's for Miravant Medical Technologies (MRVT)
- As of August 2026, Miravant Medical Technologies MRVT is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Miravant Medical Technologies using these criteria to determine its compliance status.
- Muslim investors may consider investing in Miravant Medical Technologies if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Miravant Medical Technologies by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Miravant Medical Technologies may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Miravant Medical Technologies on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Miravant Medical Technologies (MRVT)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
